Melva Blanco serves as the Senior Director of Local Delivery and Safety Translational Sciences at AbbVie, where she leverages over 20 years of extensive experience in the pharmaceutical and consumer goods industries. In her current role, Melva is a pivotal member of the Preclinical Safety...
Melva Blanco serves as the Senior Director of Local Delivery and Safety Translational Sciences at AbbVie, where she leverages over 20 years of extensive experience in the pharmaceutical and consumer goods industries. In her current role, Melva is a pivotal member of the Preclinical Safety Leadership Team, where she spearheads safety assessments and oversees the technical and regulatory documentation essential for the success of local delivery programs. Her expertise spans a diverse range of therapeutic areas, including ophthalmology, neurotoxin applications, and aesthetic indications, guiding projects from early-stage development through to late-stage clinical trials.
Melva's leadership is characterized by her ability to foster cross-functional collaboration, ensuring that diverse teams work synergistically to meet strategic and operational goals aligned with AbbVie's corporate roadmap. Her deep knowledge in toxicology and regulatory affairs enables her to navigate complex IND submissions and clinical development processes, ensuring compliance while driving innovation. Melva's commitment to public health and science education further enhances her ability to mentor emerging professionals in the field, cultivating the next generation of leaders in pharmaceutical safety and translational sciences.
Key projects under her guidance include the oversight of nonclinical safety and biological research for neurosciences programs, where she applies her robust market research skills to inform strategic decisions and optimize product development pathways. Melva's unique blend of scientific acumen and business leadership positions her as a trusted advisor to senior leaders, making her an invaluable asset to AbbVie as they continue to advance their mission of delivering transformative therapies to patients worldwide.
